Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
10 pending office actions • 8 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days
Jiangnan University is currently navigating 10 pending office actions in the Biotechnology & Pharmaceuticals technology area. The university's prosecution activity is spread across 10 distinct examiners, matching the total count of 10 pending office actions. This distribution suggests a broad range of specific biological or pharmaceutical innovations that require specialized review rather than a centralized examination process.
The portfolio is further distributed across 8 distinct art units. This variety in art units indicates that the university's filings touch upon several different sub-specialties within the broader biotechnology field. ZILBERING, ASSAF is the busiest examiner for the university, holding 1 busiest examiner pending action. With 10 examiners involved, the university must manage a wide array of examiner-specific preferences and procedural tendencies. The high ratio of examiners to actions implies that the prosecution team cannot rely on familiarity with a single reviewer's habits across multiple cases, necessitating a case-by-case tactical approach.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 5 (50%) |
| §112 only | 3 (30%) |
| Multi-statute (no §101) | 1 (10%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZILBERING, ASSAF | 1 | 35.2% | +27.8% |
| GALSTER, SAMUEL LEONARD | 1 | 50.9% | +43.2% |
| MCCLENDON, SANZA L | 1 | 80.5% | +10.7% |
| SKOKO III, JOHN JOSEPH | 1 | 53.1% | +58.2% |
| FRONDA, CHRISTIAN L | 1 | 82.4% | +14.2% |
| ZEMAN, ROBERT A | 1 | 54.3% | +27.7% |
| MORENO, LARK JULIA | 1 | 0.0% | +0.0% |
| LEBLANC, KATHERINE DEGUIRE | 1 | 34.6% | +35.8% |
| EIX, EMILY FAY | 1 | 45.5% | +78.3% |
| MAHLUM, JONATHAN DAVIS | 1 | 51.4% | +25.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18457642 | METHOD FOR PREPARING METAL INK AND ADDITIVE MANUFACTURING BASED ON PHOTO-THERMAL SYNERGISTIC CURING | MCCLENDON, SANZA L | — |
| 18322618 | METHOD FOR CONSTRUCTING A RECOMBINANT BACTERIUM WITH HIGH PRODUCTIVITY OF BETA-ELEMENE AND GERMACRENE A | FRONDA, CHRISTIAN L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18584708 | NON-ANIMAL CHONDROITIN SULFATE OLIGOSACCHARIDE AND PREPARATION METHOD THEREOF | GALSTER, SAMUEL LEONARD | — |
| 18188554 | Aquatic-plant Protein Combined Restructured Meat and Preparation Method thereof | MORENO, LARK JULIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17990976 | Application of microbiota-derived plasmalogens to Treatment of Colon Cancer | MAHLUM, JONATHAN DAVIS | 16d overdue |
| 18337631 | ANTIBODY CONJUGATE AND METHOD FOR ENHANCING IMMUNE EFFECT FUNCTION OF ANTIBODY MOLECULE | SKOKO III, JOHN JOSEPH | 14d |
| 18191919 | Bifidobacterium longum for Preventing and/or Treating Essential Hypertension | ZEMAN, ROBERT A | 63d |
| 18811929 | Oil Crystallization Promoter, Preparation Method Therefor and Use Thereof | ZILBERING, ASSAF | — |
| 18584708 | NON-ANIMAL CHONDROITIN SULFATE OLIGOSACCHARIDE AND PREPARATION METHOD THEREOF | GALSTER, SAMUEL LEONARD | — |
| 18457642 | METHOD FOR PREPARING METAL INK AND ADDITIVE MANUFACTURING BASED ON PHOTO-THERMAL SYNERGISTIC CURING | MCCLENDON, SANZA L | — |
| 18322618 | METHOD FOR CONSTRUCTING A RECOMBINANT BACTERIUM WITH HIGH PRODUCTIVITY OF BETA-ELEMENE AND GERMACRENE A | FRONDA, CHRISTIAN L | — |
| 18075454 | METHOD FOR PREPARING PROTEIN NANOPARTICLE MICROSPHERES | LEBLANC, KATHERINE DEGUIRE | — |
| Art Unit | Apps |
|---|---|
| 1765 | 1 |
| 1643 | 1 |
| 1652 | 1 |
| 1645 | 1 |
| 1793 | 1 |
| 1791 | 1 |
| 1653 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18811929 | Oil Crystallization Promoter, Preparation Method Therefor and Use Thereof | ZILBERING, ASSAF | — | §103 | Non-Final OA | — | Pending | Aug 22, 2024 |
| 18584708 | NON-ANIMAL CHONDROITIN SULFATE OLIGOSACCHARIDE AND PREPARATION METHOD THEREOF | GALSTER, SAMUEL LEONARD | — | §101§102§103§112 | Non-Final OA | — | Pending | Feb 22, 2024 |
| 18457642 | METHOD FOR PREPARING METAL INK AND ADDITIVE MANUFACTURING BASED ON PHOTO-THERMAL SYNERGISTIC CURING | MCCLENDON, SANZA L | 1765 | §112 | Final Rejection | — | Pending | Aug 29, 2023 |
| 18337631 | ANTIBODY CONJUGATE AND METHOD FOR ENHANCING IMMUNE EFFECT FUNCTION OF ANTIBODY MOLECULE | SKOKO III, JOHN JOSEPH | 1643 | §103 | Final Rejection | 14d | Pending | Jun 20, 2023 |
| 18322618 | METHOD FOR CONSTRUCTING A RECOMBINANT BACTERIUM WITH HIGH PRODUCTIVITY OF BETA-ELEMENE AND GERMACRENE A | FRONDA, CHRISTIAN L | 1652 | §112 | Final Rejection | — | Pending | May 24, 2023 |
| 18191919 | Bifidobacterium longum for Preventing and/or Treating Essential Hypertension | ZEMAN, ROBERT A | 1645 | §112 | Non-Final OA | 63d | Pending | Mar 29, 2023 |
| 18188554 | Aquatic-plant Protein Combined Restructured Meat and Preparation Method thereof | MORENO, LARK JULIA | 1793 | §103§112 | Final Rejection | — | Pending | Mar 23, 2023 |
| 18075454 | METHOD FOR PREPARING PROTEIN NANOPARTICLE MICROSPHERES | LEBLANC, KATHERINE DEGUIRE | 1791 | §103 | Final Rejection | — | Pending | Dec 06, 2022 |
| 18061585 | Genetically Engineered Bacteria Producing Lacto-N-neotetraose and Production Method Thereof | EIX, EMILY FAY | 1653 | §103 | Non-Final OA | — | Pending | Dec 05, 2022 |
| 17990976 | Application of microbiota-derived plasmalogens to Treatment of Colon Cancer | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Final Rejection | 16d overdue | Pending | Nov 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial